☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
PharmaShots Weekly Snapshots (March 07-11, 2022)
March 11, 2022
AbbVie Entered into a Co-Development & License Agreement with Gedeon Richter to Develop & Commercialize Dopamine Receptor Modulato...
March 11, 2022
Passage Bio Reports the First Patient Dosing of PBKR03 in the P-I/II (GALax-C) Trial for the Treatment of Infantile Krabbe Disease
March 11, 2022
Erasca Entered into a Clinical Trial Collaboration and Supply Agreement with Eli Lilly to Evaluate ERAS-007 and Erbitux (cetuximab...
March 11, 2022
Amarin Publishes Results of Vascepa (icosapent ethyl) in (REDUCE-IT) Study for the Treatment of Cardiovascular Diseases in JAHA 20...
March 11, 2022
Samsung Bioepis and Biogen’s Byooviz (biosimilar, ranibizumab) Receive the Health Canada Approval for the Treatment of Retinal Vas...
March 11, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions